SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 215 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $28,906 | -21.8% | 16,424 | +39.5% | 0.00% | 0.0% |
| Q4 2022 | $36,970 | +362.1% | 11,774 | +617.1% | 0.00% | – |
| Q3 2022 | $8,000 | +300.0% | 1,642 | +342.6% | 0.00% | – |
| Q2 2022 | $2,000 | +100.0% | 371 | +103.8% | 0.00% | – |
| Q1 2022 | $1,000 | -75.0% | 182 | -42.4% | 0.00% | – |
| Q1 2021 | $4,000 | – | 316 | -84.2% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 2,000 | +240.1% | 0.00% | -100.0% |
| Q2 2018 | $8,000 | – | 588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 968,505 | $12,135,000 | 1.23% |
| Golden State Equity Partners | 126,608 | $1,586,000 | 0.90% |
| McGuire Investment Group, LLC | 272,801 | $3,418,000 | 0.72% |
| Lombard Odier Asset Management (Switzerland) SA | 848,429 | $10,631,000 | 0.70% |
| Rhenman & Partners Asset Management AB | 765,000 | $9,585,000 | 0.67% |
| EMC Capital Management | 72,061 | $903,000 | 0.64% |
| WASATCH ADVISORS LP | 10,328,423 | $129,415,000 | 0.58% |
| Ceeto Capital Group, LLC | 74,000 | $927,000 | 0.45% |
| Fort Sheridan Advisors LLC | 75,945 | $952,000 | 0.38% |
| Vanguard Capital Wealth Advisors | 34,580 | $388,679,000 | 0.33% |